Read our November 2017 edition here.
Our last issue of the year includes a host of company profiles actively seeking partners and three features that cover dealmaking trends within CNS disorders, a timeline of gene therapy events and information regarding how to prepare for a pharmaceutical deal.
- Partnering for CNS disorders
- Taking a journey through gene therapy
- How to prepare for a pharmaceutical deal